ArticleCancer management and research2021

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.

Maen Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.